Skip to main content
. 2022 Jul 4;12:865292. doi: 10.3389/fonc.2022.865292

Figure 1.

Figure 1

Kaplan-Meier curves of real-world progression-free survival in patients with visceral (lung and/or liver) metastasis. sIPTW analysis (A) and PSM analysis (B); number of patients at risk are shown. LET, letrozole; PAL, palbociclib; PSM, propensity score matching; rwPFS, real-world progression-free survival; sIPTW, stabilized inverse probability treatment weighting.